Appili Therapeutics' Seed VC - II Round

Appili Therapeutics raised a round of funding on December 21, 2016. Investors include Innovacorp.

Appili is dedicated to identifying, acquiring and advancing novel therapeutics for infectious disease. The company has two anti-infective programs, ATI-1501 and ATI-1503, in its pipeline. ATI-1501 is …

Articles about Appili Therapeutics' Seed VC - II Round: